These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33311035)

  • 1. Prevalence of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus.
    Tamrakar R; Shrestha A; Tamrakar D
    Kathmandu Univ Med J (KUMJ); 2019 Oct.-Dec.; 17(68):273-278. PubMed ID: 33311035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria.
    Pokharel DR; Khadka D; Sigdel M; Yadav NK; Acharya S; Kafle RC; Shukla PS
    J Diabetes Metab Disord; 2014; 13(1):104. PubMed ID: 25469328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus Asian-Indian Patients Over the Last 15 Years using Adult Treatment Panel III of the National Cholesterol Education Program, World Health Organization, and International Diabetes Federation Criterion.
    Tuteja HS; Nassikar N; Panikar K; Tiwaskar M; Walwalkar S; Sachdev I; Kamble S; Kadir P; Mahajan A; Joshi S; Panikar V
    J Assoc Physicians India; 2024 Jun; 72(6):39-43. PubMed ID: 38881133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.
    Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS
    Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.
    Yadav D; Mahajan S; Subramanian SK; Bisen PS; Chung CH; Prasad GB
    Glob J Health Sci; 2013 Sep; 5(6):142-55. PubMed ID: 24171882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome in newly diagnosed type 2 diabetes mellitus using NCEP-ATP III, the Nnewi experience.
    Osuji CU; Nzerem BA; Dioka CE; Onwubuya EI
    Niger J Clin Pract; 2012; 15(4):475-80. PubMed ID: 23238201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome components and prevalence of cardiovascular disease among type 2 diabetic patients in Malaysia.
    Tan MC; Wong TW; Ng OC; Joseph A; Hejar AR
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):226-35. PubMed ID: 24964674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain].
    Rodríguez Bernardino A; García Polavieja P; Reviriego Fernández J; Serrano Ríos M
    Endocrinol Nutr; 2010 Feb; 57(2):60-70. PubMed ID: 20153706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study.
    Birarra MK; Gelayee DA
    BMC Cardiovasc Disord; 2018 Jul; 18(1):149. PubMed ID: 30016936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
    Sirdah MM; Abu Ghali AS; Al Laham NA
    Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: A case study from urban southeast Nigeria.
    Nwankwo M; Okamkpa CJ; Danborno B
    Diabetes Metab Syndr; 2022 Dec; 16(12):102665. PubMed ID: 36417829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome: comparison of occurrence using three definitions in hypertensive patients.
    Akintunde AA; Ayodele OE; Akinwusi PO; Opadijo GO
    Clin Med Res; 2011 Mar; 9(1):26-31. PubMed ID: 20682756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in type 2 diabetes: comparison of WHO, modified ATPIII & IDF criteria.
    Ahmed A; Khan TE; Yasmeen T; Awan S; Islam N
    J Pak Med Assoc; 2012 Jun; 62(6):569-74. PubMed ID: 22755342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Metabolic Syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil.
    do Vale Moreira NC; Hussain A; Bhowmik B; Mdala I; Siddiquee T; Fernandes VO; Montenegro Júnior RM; Meyer HE
    Diabetes Metab Syndr; 2020; 14(5):1217-1224. PubMed ID: 32682310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome among Nepalese type 2 diabetic patients.
    Tamang HK; Timilsina U; Thapa S; Singh KP; Shrestha S; Singh P; Shrestha B
    Nepal Med Coll J; 2013 Mar; 15(1):50-5. PubMed ID: 24592795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Metabolic Syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and Modified World Health Organization Definitions.
    Bee YT; Haresh KK; Rajibans S
    Malays J Nutr; 2008 Mar; 14(1):65-77. PubMed ID: 22691765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparative Assessment of Metabolic Syndrome and its Association with Vitamin D and Other Risk Factors in Type 2 Diabetes Mellitus Patients.
    Jairoun AA; Shahwan MJ; Khattab MH
    Curr Diabetes Rev; 2021; 17(2):233-242. PubMed ID: 32674733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.